Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Differential biotin labelling of the cell envelope proteins in lipopolysaccharidic diderm bacteria: Exploring the proteosurfaceome of Escherichia coli using sulfo-NHS-SS-biotin and sulfo-NHS-PEG4-bismannose-SS-biotin.

Monteiro R, Chafsey I, Leroy S, Chambon C, Hébraud M, Livrelli V, Pizza M, Pezzicoli A, Desvaux M.

J Proteomics. 2018 Jun 15;181:16-23. doi: 10.1016/j.jprot.2018.03.026. Epub 2018 Mar 30.

PMID:
29609094
2.

Shiga toxin 2 translocation across intestinal epithelium is linked to virulence of Shiga toxin-producing Escherichia coli in humans.

Tran SL, Jenkins C, Livrelli V, Schüller S.

Microbiology. 2018 Apr;164(4):509-516. doi: 10.1099/mic.0.000645. Epub 2018 Mar 13.

3.

Enterohemorrhagic Escherichia coli pathogenesis: role of Long polar fimbriae in Peyer's patches interactions.

Cordonnier C, Etienne-Mesmin L, Thévenot J, Rougeron A, Rénier S, Chassaing B, Darfeuille-Michaud A, Barnich N, Blanquet-Diot S, Livrelli V.

Sci Rep. 2017 Mar 20;7:44655. doi: 10.1038/srep44655.

4.

Probiotic and enterohemorrhagic Escherichia coli: An effective strategy against a deadly enemy?

Cordonnier C, Thévenot J, Etienne-Mesmin L, Alric M, Livrelli V, Blanquet-Diot S.

Crit Rev Microbiol. 2017 Feb;43(1):116-132. doi: 10.1080/1040841X.2016.1185602. Epub 2016 Nov 1. Review.

PMID:
27798976
5.

Increased EHEC survival and virulence gene expression indicate an enhanced pathogenicity upon simulated pediatric gastrointestinal conditions.

Roussel C, Cordonnier C, Galia W, Le Goff O, Thévenot J, Chalancon S, Alric M, Thevenot-Sergentet D, Leriche F, Van de Wiele T, Livrelli V, Blanquet-Diot S.

Pediatr Res. 2016 Nov;80(5):734-743. doi: 10.1038/pr.2016.144. Epub 2016 Jul 18.

PMID:
27429202
6.

On Blastocystis secreted cysteine proteases: a legumain-activated cathepsin B increases paracellular permeability of intestinal Caco-2 cell monolayers.

Nourrisson C, Wawrzyniak I, Cian A, Livrelli V, Viscogliosi E, Delbac F, Poirier P.

Parasitology. 2016 Nov;143(13):1713-1722. Epub 2016 Sep 9.

PMID:
27609526
7.

A secretome view of colonisation factors in Shiga toxin-encoding Escherichia coli (STEC): from enterohaemorrhagic E. coli (EHEC) to related enteropathotypes.

Monteiro R, Ageorges V, Rojas-Lopez M, Schmidt H, Weiss A, Bertin Y, Forano E, Jubelin G, Henderson IR, Livrelli V, Gobert AP, Rosini R, Soriani M, Desvaux M.

FEMS Microbiol Lett. 2016 Aug;363(16). pii: fnw179. doi: 10.1093/femsle/fnw179. Epub 2016 Jul 26. Review.

PMID:
27465489
8.

Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches.

Thévenot J, Cordonnier C, Rougeron A, Le Goff O, Nguyen HT, Denis S, Alric M, Livrelli V, Blanquet-Diot S.

Appl Microbiol Biotechnol. 2015 Nov;99(21):9097-110. doi: 10.1007/s00253-015-6704-0. Epub 2015 Jun 18.

PMID:
26084888
9.

In vitro adhesion properties of Shiga toxin-producing Escherichia coli isolated from cattle, food, and humans.

Pradel N, Etienne-Mesmin L, Thévenot J, Cordonnier C, Blanquet-Diot S, Livrelli V.

Front Microbiol. 2015 Feb 27;6:156. doi: 10.3389/fmicb.2015.00156. eCollection 2015.

10.

Dynamic In Vitro Models of the Human Gastrointestinal Tract as Relevant Tools to Assess the Survival of Probiotic Strains and Their Interactions with Gut Microbiota.

Cordonnier C, Thévenot J, Etienne-Mesmin L, Denis S, Alric M, Livrelli V, Blanquet-Diot S.

Microorganisms. 2015 Oct 23;3(4):725-45. doi: 10.3390/microorganisms3040725.

11.

Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects.

Nourrisson C, Scanzi J, Pereira B, NkoudMongo C, Wawrzyniak I, Cian A, Viscogliosi E, Livrelli V, Delbac F, Dapoigny M, Poirier P.

PLoS One. 2014 Nov 3;9(11):e111868. doi: 10.1371/journal.pone.0111868. eCollection 2014.

12.

Molecular subtyping of Blastocystis spp. using a new rDNA marker from the mitochondria-like organelle genome.

Poirier P, Meloni D, Nourrisson C, Wawrzyniak I, Viscogliosi E, Livrelli V, Delbac F.

Parasitology. 2014 Apr;141(5):670-81. doi: 10.1017/S0031182013001996. Epub 2014 Jan 27.

PMID:
24467909
13.

Survival of Escherichia coli O26:H11 exceeds that of Escherichia coli O157:H7 as assessed by simulated human digestion of contaminated raw milk cheeses.

Miszczycha SD, Thévenot J, Denis S, Callon C, Livrelli V, Alric M, Montel MC, Blanquet-Diot S, Thevenot-Sergentet D.

Int J Food Microbiol. 2014 Feb 17;172:40-8. doi: 10.1016/j.ijfoodmicro.2013.11.029. Epub 2013 Dec 4.

PMID:
24361831
14.

Enterohemorrhagic Escherichia coli O157:H7 survival in an in vitro model of the human large intestine and interactions with probiotic yeasts and resident microbiota.

Thévenot J, Etienne-Mesmin L, Denis S, Chalancon S, Alric M, Livrelli V, Blanquet-Diot S.

Appl Environ Microbiol. 2013 Feb;79(3):1058-64. doi: 10.1128/AEM.03303-12. Epub 2012 Nov 30.

15.

Two cases of urinary tract infection caused by Shiga toxin-producing Escherichia coli O157:H7 strains.

Gadea Mdel P, Deza N, Mota MI, Carbonari C, Robatto M, D'Astek B, Balseiro V, Bazet C, Rügnitz E, Livrelli V, Schelotto F, Rivas M, Varela G.

Rev Argent Microbiol. 2012 Apr-Jun;44(2):94-6.

PMID:
22997767
16.

Relevance and challenges in modeling human gastric and small intestinal digestion.

Guerra A, Etienne-Mesmin L, Livrelli V, Denis S, Blanquet-Diot S, Alric M.

Trends Biotechnol. 2012 Nov;30(11):591-600. doi: 10.1016/j.tibtech.2012.08.001. Epub 2012 Sep 10. Review.

PMID:
22974839
17.

Interactions with M cells and macrophages as key steps in the pathogenesis of enterohemorrhagic Escherichia coli infections.

Etienne-Mesmin L, Chassaing B, Sauvanet P, Denizot J, Blanquet-Diot S, Darfeuille-Michaud A, Pradel N, Livrelli V.

PLoS One. 2011;6(8):e23594. doi: 10.1371/journal.pone.0023594. Epub 2011 Aug 17.

18.

Development and evaluation of a real-time PCR assay for detection and quantification of blastocystis parasites in human stool samples: prospective study of patients with hematological malignancies.

Poirier P, Wawrzyniak I, Albert A, El Alaoui H, Delbac F, Livrelli V.

J Clin Microbiol. 2011 Mar;49(3):975-83. doi: 10.1128/JCM.01392-10. Epub 2010 Dec 22.

19.

Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model.

Etienne-Mesmin L, Livrelli V, Privat M, Denis S, Cardot JM, Alric M, Blanquet-Diot S.

Appl Environ Microbiol. 2011 Feb;77(3):1127-31. doi: 10.1128/AEM.02130-10. Epub 2010 Dec 3.

20.

[Development of a real-time PCR assay for quantitative diagnosis of Toxoplasma gondii after allogeneic bone marrow transplantation].

Daval S, Poirier P, Armenaud J, Cambon M, Livrelli V.

Pathol Biol (Paris). 2010 Feb;58(1):104-9. doi: 10.1016/j.patbio.2009.07.013. Epub 2009 Nov 4. French.

PMID:
19892493
21.

Detection of stx1, stx2, and eae genes of enterohemorrhagic Escherichia coli using SYBR Green in a real-time polymerase chain reaction.

Chassagne L, Pradel N, Robin F, Livrelli V, Bonnet R, Delmas J.

Diagn Microbiol Infect Dis. 2009 May;64(1):98-101. doi: 10.1016/j.diagmicrobio.2009.01.031.

PMID:
19362260
22.

Molecular analysis of shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients and dairy samples in France.

Pradel N, Bertin Y, Martin C, Livrelli V.

Appl Environ Microbiol. 2008 Apr;74(7):2118-28. doi: 10.1128/AEM.02688-07. Epub 2008 Feb 1.

23.

Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates.

Girardeau JP, Dalmasso A, Bertin Y, Ducrot C, Bord S, Livrelli V, Vernozy-Rozand C, Martin C.

J Clin Microbiol. 2005 Dec;43(12):6098-107.

24.
25.
26.

Contribution of the twin arginine translocation system to the virulence of enterohemorrhagic Escherichia coli O157:H7.

Pradel N, Ye C, Livrelli V, Xu J, Joly B, Wu LF.

Infect Immun. 2003 Sep;71(9):4908-16.

27.

Effect of diet on Shiga toxin-producing Escherichia coli (STEC) growth and survival in rumen and abomasum fluids.

Boukhors K, Pradel N, Girardeau JP, Livrelli V, Ou Saïd AM, Contrepois M, Martin C.

Vet Res. 2002 Jul-Aug;33(4):405-12.

28.

Genomic subtraction to identify and characterize sequences of Shiga toxin-producing Escherichia coli O91:H21.

Pradel N, Leroy-Setrin S, Joly B, Livrelli V.

Appl Environ Microbiol. 2002 May;68(5):2316-25.

30.

Heterogeneity of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients, cattle, and food samples in central France.

Pradel N, Boukhors K, Bertin Y, Forestier C, Martin C, Livrelli V.

Appl Environ Microbiol. 2001 Jun;67(6):2460-8.

31.

[Verotoxin-producing Escherichia coli infections: study of its prevalence in children in the Auvergne region].

Pradel N, De Champs C, Palcoux JB, Sirot J, Forestier C, Joly B, Scheutz F, Livrelli V.

Arch Pediatr. 2000 Jun;7 Suppl 3:544s-550s. French.

PMID:
10941478
32.

Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France.

Pradel N, Livrelli V, De Champs C, Palcoux JB, Reynaud A, Scheutz F, Sirot J, Joly B, Forestier C.

J Clin Microbiol. 2000 Mar;38(3):1023-31.

33.

Non-O157:H7 Stx2-producing Escherichia coli strains associated with sporadic cases of hemolytic-uremic syndrome in adults.

Bonnet R, Souweine B, Gauthier G, Rich C, Livrelli V, Sirot J, Joly B, Forestier C.

J Clin Microbiol. 1998 Jun;36(6):1777-80.

34.

Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratia clinical isolates involved in nosocomial infections.

Livrelli V, De Champs C, Di Martino P, Darfeuille-Michaud A, Forestier C, Joly B.

J Clin Microbiol. 1996 Aug;34(8):1963-9.

35.

A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections.

Di Martino P, Livrelli V, Sirot D, Joly B, Darfeuille-Michaud A.

Infect Immun. 1996 Jun;64(6):2266-73.

36.

Molecular characterization and adhesive properties of CF29K, an adhesin of Klebsiella pneumoniae strains involved in nosocomial infections.

Di Martino P, Bertin Y, Girardeau JP, Livrelli V, Joly B, Darfeuille-Michaud A.

Infect Immun. 1995 Nov;63(11):4336-44.

37.

Escherichia coli strains involved in diarrhea in France: high prevalence and heterogeneity of diffusely adhering strains.

Jallat C, Livrelli V, Darfeuille-Michaud A, Rich C, Joly B.

J Clin Microbiol. 1993 Aug;31(8):2031-7.

39.
40.

A novel plasmid-mediated extended-spectrum beta-lactamase not derived from TEM- or SHV-type enzymes.

Bernard H, Tancrede C, Livrelli V, Morand A, Barthelemy M, Labia R.

J Antimicrob Chemother. 1992 May;29(5):590-2. No abstract available.

PMID:
1624397
41.

Sequence and molecular characterization of the ROB-1 beta-lactamase gene from Pasteurella haemolytica.

Livrelli V, Peduzzi J, Joly B.

Antimicrob Agents Chemother. 1991 Feb;35(2):242-51.

42.

Genetic determinant of the ROB-1 beta-lactamase in bovine and porcine Pasteurella strains.

Livrelli VO, Darfeuille-Richaud A, Rich CD, Joly BH, Martel JL.

Antimicrob Agents Chemother. 1988 Aug;32(8):1282-4.

43.

Isolation and molecular characterization of an ROB-1 beta-lactamase plasmid in a Haemophilus influenzae strain in France.

Livrelli V, Darfeuille-Michaud A, Rich C, Joly B, Dabernat H.

Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):583-5. No abstract available.

PMID:
3141181
44.

Characterization of Haemophilus influenzae isolated from patients with otitis media.

Dabernat H, Delmas C, Rich C, Livrelli V, Joly B.

Eur J Clin Microbiol Infect Dis. 1988 Apr;7(2):219-25.

PMID:
3134225
45.

[A new mechanism of resistance to ampicillin by production of beta-lactamase ROB-1 in a strain of Haemophilus influenzae isolated in France].

Joly B, Delmas C, Rich C, Prere MF, Livrelli V, Dabernat H.

Presse Med. 1987 May 16;16(18):916-7. French. No abstract available.

PMID:
2954134

Supplemental Content

Loading ...
Support Center